Outcomes of patients with post-hepatectomy hypophosphatemia: A narrative review

Figure 1 Pathophysiology and etiology outlining hypophosphatemia. 1,25(OH)₂D: 1,25 dihydroxyvitamin D; 25OHD: 25-hydroxyvitamin D; FGF-23: Fibroblast growth factor-23; NAD: Nicotinamide adenine dinucleotide; NAM: Nicotinamide; Nampt: Nicotinamide phosphoribosyltransferase; PTH: Parathyroid hormone.

Figure 2 Schematic diagram summarizing the postulated pathophysiology of the impact of post-hepatectomy hypophosphatemia on post-operative outcomes, as well as summary of the advantages (green) and disadvantages (blue) of post-hepatectomy hypophosphatemia in existing literature on post-operative outcomes. PHLF: Post-hepatectomy liver failure.